Trademarks = 3

Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Matthew Welsch (2 out of 12 patents)

David Spiegel (2 out of 43 patents)

Allen B Reitz (1 out of 101 patents)

4. H Marie Loughran (1 out of 9 patents)

5. Jeffrey Claude Pelletier (1 out of 21 patents)

6. Anna Bunin (1 out of 4 patents)

7. Lawrence G Iben (1 out of 2 patents)

8. Douglas Manion (1 out of 2 patents)

2 patents: Sort by Forward Citations

1. 12162892 - CD16a binding agents and uses thereof (2024-12-10),

2. 10780084 - Antibody-recruiting molecules for the treatment of cancer (2020-09-22),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

2 Patents

#67 in New Haven, CT

#1,782 in Connecticut

#94,782 in US

New Haven, CT, United States of America

Kleo Pharmaceuticals, Inc.

Forward Citations = 0

8 inventors:

Matthew Welsch (2 out of 12 patents)

David Spiegel (2 out of 43 patents)

Allen B Reitz (1 out of 101 patents)

4. H Marie Loughran (1 out of 9 patents)

5. Jeffrey Claude Pelletier (1 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kleo Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/kleo-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]